Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 10,719,110 | 10,719,110 | 0 | $219.42M | $194.12M | 24.29% | -$25.30M |
| Cidara Therapeutics Inc | 703,080 | 2,500,680 | +1,797,600 | $15.14M | $121.81M | 15.24% | +$106.66M |
| Nuvalent Inc | 1,447,267 | 1,447,267 | 0 | $102.64M | $110.43M | 13.82% | +$7.79M |
| Pharvaris N V COM | 3,303,381 | 3,303,381 | 0 | $51.86M | $58.14M | 7.27% | +$6.28M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,689,707 | 2,482,250 | -207,457 | $48.79M | $46.24M | 5.79% | -$2.55M |
| Savara Inc.(SVRA) | 17,600,621 | 17,600,621 | 0 | $48.75M | $40.13M | 5.02% | -$8.62M |
| Solid Biosciences Inc | 7,911,669 | 7,911,669 | 0 | $29.27M | $38.53M | 4.82% | +$9.26M |
| Disc Medicine, Inc.(IRON) | 983,500 | 583,500 | -400,000 | $48.82M | $30.90M | 3.87% | -$17.92M |
| Olema Pharmaceuticals, Inc.(OLMA) | 6,843,954 | 6,843,954 | 0 | $25.73M | $29.16M | 3.65% | +$3.42M |
| Rapid Micro Biosystems, Inc.CL A(RPID) | 8,434,560 | 8,434,560 | 0 | $22.27M | $29.10M | 3.64% | +$6.83M |
| Upstream Bio, Inc.(UPB) | 2,295,322 | 2,439,538 | +144,216 | $14.05M | $26.79M | 3.35% | +$12.74M |
| Cabaletta Bio, Inc.(CABA) | 2,760,888 | 9,677,125 | +6,916,237 | $3.82M | $14.71M | 1.84% | +$10.89M |
| Tango Therapeutics, Inc.(TNGX) | 2,712,008 | 2,712,008 | 0 | $3.72M | $13.89M | 1.74% | +$10.17M |
| Annexon, Inc.(ANNX) | 5,249,069 | 5,249,069 | 0 | $10.13M | $12.60M | 1.58% | +$2.47M |
| Kyverna Therapeutics, Inc.(KYTX) | 3,368,370 | 3,368,370 | 0 | $6.50M | $10.34M | 1.29% | +$3.84M |
| Atea Pharmaceuticals, Inc.(AVIR) | 2,485,638 | 2,485,638 | 0 | $7.43M | $8.95M | 1.12% | +$1.52M |
| Xilio Therapeutics, Inc.(XLO) | 4,566,817 | 4,566,817 | 0 | $3.31M | $3.10M | 0.39% | -$203.2K |
| Century Therapeutics, Inc.(IPSC) | 5,410,361 | 5,410,361 | 0 | $2.58M | $3.02M | 0.38% | +$447.4K |
| Mersana Therapeutics Inc | 8,663,673 | 8,663,673 | 0 | $2.98M | $2.56M | 0.32% | -$417.6K |
| C4 Therapeutics, Inc.(CCCC) | 1,111,910 | 1,111,910 | 0 | $1.78M | $1.59M | 0.20% | -$189.0K |
| Invivyd, Inc.(IVVD) | 1,799,595 | 1,799,595 | 0 | $1.09M | $1.29M | 0.16% | +$197.4K |
| X4 Pharmaceuticals, Inc.(XFOR) | 0 | 563,859 | +563,859 | $0 | $1.07M | 0.13% | +$1.07M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 100,000 | 100,000 | 0 | $899.0K | $800.0K | 0.10% | -$99.0K |
| Nautilus Biotechnology, Inc.(NAUT) | 1,072,421 | 0 | -1,072,421 | $923.4K | $0 | — | -$923.4K |
| X4 Pharmaceuticals, Inc.(XFOR) | 16,915,784 | 0 | -16,915,784 | $4.00M | $0 | — | -$4.00M |